GenMark Diagnostics has appointed Hany Massarany to be president and CEO and a member of the board of directors. Massarany formerly was president of Ventana Medical Systems and head of Roche Tissue Diagnostics. He also held executive management positions at Bayer Diagnostics and Chiron Diagnostics in the Asia Pacific and US regions.
Fluidigm has appointed Evan Jones to be a class I director until its 2011 stockholder meeting. Jones is a co-founder of Digene. He currently is an executive chairman at OpGen and a managing member of jVen Capital, a life sciences investment company.
The American College of Medical Genetics has elected four new directors. Gail Herman, who is the new president-elect of the board, is an investigator at the Center for Molecular & Human Genetics at Nationwide Children's Hospital and a professor at Ohio State University.
The three other new directors include Mira Irons of Children's Hospital of Boston, who is ACMG's clinical genetics director; Christa Lese Martin of Emory University School of Medicine, who is cytogenetics director; and Soma Das of the University of Chicago, who is molecular genetics director. All of the new directors will serve six-year terms through 2017.